ProQR Therapeutics N.V. (PRQR) reporting calendar
ProQR Therapeutics N.V. files periodic reports with the SEC as PRQR on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 12 Mar 2026
- Reports on record
- 12
Open PRQR market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 12 Mar 2026 | 71 days | 0001104659-26-026713 |
| 20-F | 31 Dec 2024 | 13 Mar 2025 | 72 days | 0001558370-25-002851 |
| 20-F | 31 Dec 2023 | 13 Mar 2024 | 73 days | 0001558370-24-003060 |
| 20-F | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001558370-23-004917 |
| 20-F | 31 Dec 2021 | 29 Apr 2022 | 119 days | 0001558370-22-006395 |
| 20-F | 31 Dec 2020 | 24 Mar 2021 | 83 days | 0001558370-21-003399 |
| 20-F | 31 Dec 2019 | 31 Mar 2020 | 91 days | 0001558370-20-003457 |
| 20-F | 31 Dec 2018 | 28 Mar 2019 | 87 days | 0001558370-19-002525 |
| 20-F | 31 Dec 2017 | 30 Mar 2018 | 89 days | 0001558370-18-002577 |
| 20-F | 31 Dec 2016 | 31 Mar 2017 | 90 days | 0001193125-17-106844 |
| 20-F | 31 Dec 2015 | 31 Mar 2016 | 91 days | 0001193125-16-525912 |
| 20-F | 31 Dec 2014 | 22 Apr 2015 | 112 days | 0001193125-15-142091 |
Source: SEC EDGAR company submissions for CIK 0001612940. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.